p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma

International Journal of Cancer

Volumn 69, Issue 3, 1996, Pages 200-204

  Lim, Berenice H G ^a   Soong, Richie ^a   Grieu, Fabienne ^a   Robbins, Peter D ^b   House, Anthony K ^a   Iacopetta, Barry J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Western Australian Centre for Pathology and Medical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; REGRESSION ANALYSIS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030056208     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960621)69:3<200::AID-IJC9>3.0.CO;2-3     Document Type: Article

References (21)

1. BAAS, I.O., MULDER, J.W.R., OFFERHAUS, G.J.A., VOGELSTEIN, B. and HAMILTON, S.R., An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172, 5-12 (1994).
2. BERGH, J., NORBERG, T., SJÖGREN, S., LINDGREN, A. and HOLMBERG, L., Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature (Med.), 1, 1029-1034 (1995).
3. BOSARI, S., VIALE, G., RONCALLI, M., GRAZIANI, D., BORSANI, G., LEE, A.K.C. and COGGI, G., p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Amer. J. Pathol., 147, 790-798 (1995).
4. DIX, B., ROBBINS, P., CARELLO, S., HOUSE, A. and IACOPETTA, B., Comparison of p53 mutation and protein overexpression in colorectal carcinomas. Brit. J. Cancer, 70, 585-590 (1994a).
5. Dix, B.R., ROBBINS, P.D., SOONG, R., JENNER, D., HOUSE, A.K. and IACOPETTA, B.J., The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short term prognostic indicators of survival. Int. J. Cancer, 59, 747-751 (19946).
6. DIX, B.R., ROBBINS, P.D., SPAGNOLO, D.V., PADOVAN, G.L., HOUSE, A.K. and IACOPETTA, B.J., Clonal analysis of colorectal tumours using K-ras and p53 gene mutations as markers. Diagnostic mol. Pathol., 4, 261-265 (1995).
7. GABBERT, H.E., MULLER, W., SCHNEIDERS, A., MEIER, S. and HOMMEL, G., The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer, 76, 720-726 (1995).
8. HOLLSTEIN, M., RICE, K., GREENBLATT, M.S., SOUSSI, T., FUCHS, R., SARLIE, T., HOVIG, E., SMITH-SORENSON, B., MONTESANO, R. and HARRIS, C.C., Database of p53 gene somatic mutations in human tumours and cell lines. Nucl. Acids Res., 22, 3551-3555 (1994).
9. HONGYO, T., BUZARD, G.S., PALLI, D., WEGHORST, C.M., AMOROSI, A., GALLI, M., CAPORASO, N.E., FRAUMENI, J.F. and RICE, J.M., Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res., 55, 2665-2672 (1995).
10. JOYPAUL, B.V., HOPWOOD, D., NEWMAN, E.L., QURESHI, S., GRANT, A., OGSTON, S.A., LANE, D.P. and CUSCHIERI, A., The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Brit. J. Cancer, 69, 943-946 (1994).
11. LANE, D.P., The regulation of p53 function: Steiner Award Lecture. Int. J. Cancer, 57, 623-627 (1994).
12. LAUREN, P., The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta pathol. microbiol. Scand. 64, 31-49 (1965).
13. MARTIN, H.M., FILIPE, M.I., MORRIS, R.W., LANE, D.P. and SILVESTRE, F., p53 expression and prognosis in gastric carcinoma. Int. J. Cancer, 50, 859-862 (1992).
14. MOTOJIMA, K., FURUI, J., KOHARA, N., ITO, T. and KANEMATSU, T., Expression of p53 protein in gastric carcinomas is not independently prognostic. Surgery, 116, 890-895 (1994).
15. RANZANI, G.N., LUINETTI, O., PADOVAN, L.S., CALISTRI, D., RENAULT, B., BURREL, M., AMADORI, D., FIOCCA, R. and SOLCIA, E., p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol., Biomarkers Prevent., 4, 223-231 (1995).
16. RENAULT, B., VAN DE BROEK, M., FODDE, R., WIJEN, J., PELLEOATA, N.S., AMADORI, D., KHAN, P.M. and RANZANI, G.N., Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res., 53, 2614-2617 (1993).
17. SCHNEIDER, B.C., HILSENBECK, S.G., MENSEL, C.H., PEKKEL, V., SHELTON, C.H., RODRIGUEZ-MARTINEZ, H.A., GUTIERREZ-DIAZ, M.E., PULITZER, D.R. and ALLRED, D.C., p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos. Virchows Archiv., 424, 187-193 (1994).
18. SERUCA, R., DAVID, L., HOLM, R., NESLAND, J.M., FANGAN, B.M., CASTEDO, S., SOBRINHO-SIMOES, M. and BORRESEN, A.L., p5.7 mutations in gastric carcinomas. Brit. J. Cancer, 65, 708-710 (1992).
19. STRICKLER, J.G., ZHENG, J., SHU, Q., BURGART, L.J., ALBERTS, S.R. and SHIBATA, D., p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. Cancer Res., 54, 4750-4755 (1994).
20. WHELAN, S.L., PARKIN, D.M. and MASUYER, E. (eds), Trends in cancer incidence and mortality. Lyon, France, IARC Scientific Publications (1993).
21. WYNFORD-THOMAS, D., p53 in tumour pathology: can we trust immunocytochemistry? J. Pathol., 166, 329-330 (1992).